z-logo
open-access-imgOpen Access
Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report
Author(s) -
Soji Toda,
Mei Kadoya,
Ai Matsui,
Daisuke Murayama,
Hiroyuki Iwasaki
Publication year - 2022
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-22-276
Subject(s) - medicine , lenvatinib , levothyroxine , thyroid carcinoma , gastroenterology , thyroid , thyroid cancer , endocrinology
Hyperthyroidism after total thyroidectomy is extremely rare. No studies have investigated hyperthyroidism during multiple kinase inhibitor treatment for advanced thyroid carcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom